Saturday, June 21, 2025 | 01:25 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Alembic Pharma shares jump over 8% on JV with Orbicular Pharma

Image

Press Trust of India Mumbai
Shares of Alembic Pharmaceuticals Ltd (APL) today surged over 8 per cent after the company entered into a joint venture with Orbicular Pharmaceutical to develop, manufacture and commercialise dermatology products for global markets.

The stock climbed 8.14 per cent to Rs 618 on BSE.

At NSE, it zoomed 8 per cent to Rs 618.25.

APL today informed BSE it has entered into a joint venture with Orbicular Pharmaceutical Technologies and Dr M S Mohan.

"APL and Orbicular will own 60 per cent and 40 per cent of the equity capital of Aleor when the transaction is completed," the Vadodara-based company said in a BSE filing.
 

It further said: "The joint venture agreement has standard terms including transfer of employees, financing and borrowing, management functioning, restriction on transfer of shares, non-compete, non-solicitation and termination events and consequences."

Mohan is one of the founders of Orbicular Pharmaceutical Technologies.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 21 2016 | 1:22 PM IST

Explore News